##### 



Exhibit 31 CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Daniel G. Holman, certify that: 1. I have reviewed this annual report on Form 10-KSB of Uroplasty, Inc. (the
Registrant); 2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report. 3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the Registrant
as of, and for, the periods presented in this report. 4. The Registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and we have: (a) designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the Registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared; (b) evaluated the effectiveness of the Registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and (c) disclosed in this report any change in the Registrants internal control
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15a-15(f)) that occurred during the Registrants most recent fiscal quarter
(the Registrants fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the
Registrants internal control over financial reporting. 5. The Registrants other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
Registrants auditors and the audit committee of Registrants Board of
Directors (or persons performing the equivalent function): (a) all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the Registrants ability to record, process,
summarize and report financial information; and (b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the Registrants internal control over
financial reporting. Date:   July 29, 2004.By
    
    /s/ DANIEL G. HOLMANDaniel G. Holman, President, Chief Executive Officer andChief Financial Officer (Principal Financial Officer)




---



##### 



CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Arie J. Koole, certify that: 1. I have reviewed this annual report on Form 10-KSB of Uroplasty, Inc. (the
Registrant); 2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report. 3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the Registrant
as of, and for, the periods presented in this report. 4. The Registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and we have: (a) designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the Registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared; (b) evaluated the effectiveness of the Registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and (c) disclosed in this report any change in the Registrants internal control
over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15a-15(f)) that occurred during the Registrants most recent fiscal quarter
(the Registrants fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the
Registrants internal control over financial reporting. 5. The Registrants other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
Registrants auditors and the audit committee of Registrants Board of
Directors (or persons performing the equivalent function): (a) all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the Registrants ability to record, process,
summarize and report financial information; and (b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the Registrants internal control over
financial reporting. Date:   July 29, 2004.By
    
    /s/ ARIE J. KOOLEArie J. Koole, Controller (Principal Accounting Officer)